Skip to main content
. 2015 May 21;10(5):e0127448. doi: 10.1371/journal.pone.0127448

Table 4. Possible risk factors and outcomes of Multi-Drug Resistant (MDR) and Extensively- Drug Resistant (XDR) infections (Pan-drug Resistant infections were not considered due to the small sample size).

MDR (47) XDR (15) P
CAI/ HAI/ HCAI, n (%) 2 (4)/ 26 (55)/ 19 (40.5) 2 (13)/ 7 (47)/ 6 (40) n.s.
Antibiotic prophylaxis, n (%) 9 (19) 0 (0) n.s.
Additional bed, n (%) 20 (42.5) 10 (67) n.s.
Use of antibiotics in the last 30 days, n (%) 18 (38) 6 (40) n.s.
Hospitalizations in the last 6 months, n (%) 33 (70) 7 (47) n.s.
Infections in the last 12 months, n (%) 19 (40,5) 6 (40) n.s.
Failure of empirical antibiotic therapy, n (%) 28 (60) 14 (93) 0.01
Deterioration in renal function, n (%) 8 (17) 3 (20) n.s.
In-hospital mortality, n (%) 12 (25) 6 (40) n.s.
Hospital stay (from the diagnosis of infection) (days) 17.8 ± 12.7 28 ± 37.8 n.s.